Last 12 months
Inside the activity.
2 purchase rows · 30 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 2 | 3 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 7 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 03, 2020 Filed Jan 8, 2020 01:50 UTC |
SKYLER JAY SDirector
|
SaleCommon Stock | 14,456 | $218.14 | $3,153,417.38 |
DisclosureSEC source: 0001093557-20-000006 · edgardoc.xml · nonDerivative · entry 3 SKYLER JAY S · CIK 0001236386 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Partnership Disclosed balance after: 33,503 F1 · shares: On August 6, 2019, Mr. Skyler adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Skyler. The shares set forth above were sold pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $217.66 to $218.63. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| January 03, 2020 Filed Jan 8, 2020 01:50 UTC |
SKYLER JAY SDirector
|
SaleCommon Stock | 5,564 | $217.31 | $1,209,127.31 |
DisclosureSEC source: 0001093557-20-000006 · edgardoc.xml · nonDerivative · entry 2 SKYLER JAY S · CIK 0001236386 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Partnership Disclosed balance after: 47,959 F1 · shares: On August 6, 2019, Mr. Skyler adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Skyler. The shares set forth above were sold pursuant to the 10b5-1 Plan. F3 · price: This transaction was executed in multiple trades at prices ranging from $216.66 to $217.63. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| January 03, 2020 Filed Jan 8, 2020 01:50 UTC |
SKYLER JAY SDirector
|
SaleCommon Stock | 2,700 | $216.16 | $583,636.05 |
DisclosureSEC source: 0001093557-20-000006 · edgardoc.xml · nonDerivative · entry 1 SKYLER JAY S · CIK 0001236386 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Partnership Disclosed balance after: 53,523 F1 · shares: On August 6, 2019, Mr. Skyler adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Skyler. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $215.59 to $216.53. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| January 02, 2020 Filed Jan 7, 2020 02:05 UTC |
ALTMAN STEVEN RDirector
|
SaleCommon Stock | 792 | $220.02 | $174,259.48 |
DisclosureSEC source: 0001093557-20-000002 · edgardoc.xml · nonDerivative · entry 4 ALTMAN STEVEN R · CIK 0001191307 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 46,304 F1 · shares: On August 6, 2018, Mr. Altman adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Altman. The shares set forth above were sold pursuant to the 10b5-1 Plan. F6 · price: This transaction was executed in multiple trades at prices ranging from $219.75 to $220.70. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Steven R. and Lisa J. Altman, TTEE's Altman Family Trust DTD 8/21/92, with respect to which the reporting person is a trustee. Read SEC document |
| January 02, 2020 Filed Jan 7, 2020 02:05 UTC |
ALTMAN STEVEN RDirector
|
SaleCommon Stock | 737 | $218.61 | $161,112.55 |
DisclosureSEC source: 0001093557-20-000002 · edgardoc.xml · nonDerivative · entry 3 ALTMAN STEVEN R · CIK 0001191307 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 47,096 F1 · shares: On August 6, 2018, Mr. Altman adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Altman. The shares set forth above were sold pursuant to the 10b5-1 Plan. F5 · price: This transaction was executed in multiple trades at prices ranging from $218.46 to $219.28. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Steven R. and Lisa J. Altman, TTEE's Altman Family Trust DTD 8/21/92, with respect to which the reporting person is a trustee. Read SEC document |
| January 02, 2020 Filed Jan 7, 2020 02:05 UTC |
ALTMAN STEVEN RDirector
|
SaleCommon Stock | 327 | $217.77 | $71,209.19 |
DisclosureSEC source: 0001093557-20-000002 · edgardoc.xml · nonDerivative · entry 2 ALTMAN STEVEN R · CIK 0001191307 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 47,833 F1 · shares: On August 6, 2018, Mr. Altman adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Altman. The shares set forth above were sold pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $217.29 to $218.16. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Steven R. and Lisa J. Altman, TTEE's Altman Family Trust DTD 8/21/92, with respect to which the reporting person is a trustee. Read SEC document |
| January 02, 2020 Filed Jan 7, 2020 02:05 UTC |
ALTMAN STEVEN RDirector
|
SaleCommon Stock | 644 | $216.23 | $139,253.15 |
DisclosureSEC source: 0001093557-20-000002 · edgardoc.xml · nonDerivative · entry 1 ALTMAN STEVEN R · CIK 0001191307 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 48,160 F1 · shares: On August 6, 2018, Mr. Altman adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Altman. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $216.13 to $216.32. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Steven R. and Lisa J. Altman, TTEE's Altman Family Trust DTD 8/21/92, with respect to which the reporting person is a trustee. Read SEC document |
| December 23, 2019 Filed Dec 24, 2019 00:42 UTC |
Pacelli Steven RobertEVP Strategy and Corporate Dev
|
SaleCommon Stock | 200 | $213.65 | $42,730.00 |
DisclosureSEC source: 0001093557-19-000263 · edgardoc.xml · nonDerivative · entry 2 Pacelli Steven Robert · CIK 0001359098 · EVP Strategy and Corporate Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,687 F1 · shares: On June 11, 2019, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $213.63 to $213.67. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 38,823 unvested restricted stock units, 14,987 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 19,251 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 4,585 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| December 23, 2019 Filed Dec 24, 2019 00:42 UTC |
Pacelli Steven RobertEVP Strategy and Corporate Dev
|
SaleCommon Stock | 1,332 | $213.10 | $283,846.14 |
DisclosureSEC source: 0001093557-19-000263 · edgardoc.xml · nonDerivative · entry 1 Pacelli Steven Robert · CIK 0001359098 · EVP Strategy and Corporate Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,887 F1 · shares: On June 11, 2019, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $212.61 to $213.59. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 38,823 unvested restricted stock units, 14,987 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 19,251 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 4,585 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| December 23, 2019 Filed Dec 24, 2019 00:42 UTC |
DOUBLEDAY RICHARDEVP Chief Commercial Officer
|
SaleCommon Stock | 202 | $213.61 | $43,149.58 |
DisclosureSEC source: 0001093557-19-000262 · edgardoc.xml · nonDerivative · entry 2 DOUBLEDAY RICHARD · CIK 0001466545 · EVP Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 13,778 F1 · shares: On June 3, 2019, Mr. Doubleday adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Doubleday. The shares set forth above were sold pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $213.55 to $213.79. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Doubleday Living Trust U/A/D 5/26/2015, with respect to which the reporting person is a trustee. Read SEC document |
| December 23, 2019 Filed Dec 24, 2019 00:42 UTC |
DOUBLEDAY RICHARDEVP Chief Commercial Officer
|
SaleCommon Stock | 1,331 | $212.93 | $283,407.97 |
DisclosureSEC source: 0001093557-19-000262 · edgardoc.xml · nonDerivative · entry 1 DOUBLEDAY RICHARD · CIK 0001466545 · EVP Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 13,980 F1 · shares: On June 3, 2019, Mr. Doubleday adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Doubleday. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $212.55 to $213.45. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Doubleday Living Trust U/A/D 5/26/2015, with respect to which the reporting person is a trustee. Read SEC document |
| December 16, 2019 Filed Dec 17, 2019 02:17 UTC |
AUGUSTINOS NICHOLASDirector
|
SaleCommon Stock | 1,812 | $206.14 | $373,525.68 |
DisclosureSEC source: 0001093557-19-000259 · edgardoc.xml · nonDerivative · entry 1 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,042 F1 · shares: On March 1, 2019, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 2,676 restricted stock units which were granted on May 31, 2019 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2020 Annual Meeting. Read SEC document |
| December 12, 2019 Filed Dec 17, 2019 02:16 UTC |
KAHN BARBARADirector
|
SaleCommon Stock | 100 | $212.30 | $21,230.00 |
DisclosureSEC source: 0001093557-19-000258 · edgardoc.xml · nonDerivative · entry 10 KAHN BARBARA · CIK 0001520391 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 11,266 F1 · shares: On September 13, 2019, Ms. Kahn adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Kahn. The exercise and sale of shares set forth above were pursuant to the 10b5-1 Plan. F3 · balance_after: Shares are held by the Barbara Kahn TTEE Barbara Kahn Rev TRT DTD 6/26/96 & Robert Meyer TTEE Robert Meyer Rev Trst DTD 6/26/96, with respect to which the reporting person is a trustee. Read SEC document |
| December 12, 2019 Filed Dec 17, 2019 02:16 UTC |
KAHN BARBARADirector
|
SaleCommon Stock | 500 | $211.39 | $105,692.95 |
DisclosureSEC source: 0001093557-19-000258 · edgardoc.xml · nonDerivative · entry 9 KAHN BARBARA · CIK 0001520391 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 11,366 F1 · shares: On September 13, 2019, Ms. Kahn adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Kahn. The exercise and sale of shares set forth above were pursuant to the 10b5-1 Plan. F10 · price: This transaction was executed in multiple trades at prices ranging from $211.12 to $211.90. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Shares are held by the Barbara Kahn TTEE Barbara Kahn Rev TRT DTD 6/26/96 & Robert Meyer TTEE Robert Meyer Rev Trst DTD 6/26/96, with respect to which the reporting person is a trustee. Read SEC document |
| December 12, 2019 Filed Dec 17, 2019 02:16 UTC |
KAHN BARBARADirector
|
SaleCommon Stock | 800 | $210.57 | $168,452.40 |
DisclosureSEC source: 0001093557-19-000258 · edgardoc.xml · nonDerivative · entry 8 KAHN BARBARA · CIK 0001520391 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 11,866 F1 · shares: On September 13, 2019, Ms. Kahn adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Kahn. The exercise and sale of shares set forth above were pursuant to the 10b5-1 Plan. F9 · price: This transaction was executed in multiple trades at prices ranging from $209.83 to $210.81. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Shares are held by the Barbara Kahn TTEE Barbara Kahn Rev TRT DTD 6/26/96 & Robert Meyer TTEE Robert Meyer Rev Trst DTD 6/26/96, with respect to which the reporting person is a trustee. Read SEC document |
| December 12, 2019 Filed Dec 17, 2019 02:16 UTC |
KAHN BARBARADirector
|
SaleCommon Stock | 100 | $208.54 | $20,854.00 |
DisclosureSEC source: 0001093557-19-000258 · edgardoc.xml · nonDerivative · entry 7 KAHN BARBARA · CIK 0001520391 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 12,666 F1 · shares: On September 13, 2019, Ms. Kahn adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Kahn. The exercise and sale of shares set forth above were pursuant to the 10b5-1 Plan. F3 · balance_after: Shares are held by the Barbara Kahn TTEE Barbara Kahn Rev TRT DTD 6/26/96 & Robert Meyer TTEE Robert Meyer Rev Trst DTD 6/26/96, with respect to which the reporting person is a trustee. Read SEC document |
| December 12, 2019 Filed Dec 17, 2019 02:16 UTC |
KAHN BARBARADirector
|
SaleCommon Stock | 600 | $207.67 | $124,603.02 |
DisclosureSEC source: 0001093557-19-000258 · edgardoc.xml · nonDerivative · entry 6 KAHN BARBARA · CIK 0001520391 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 12,766 F1 · shares: On September 13, 2019, Ms. Kahn adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Kahn. The exercise and sale of shares set forth above were pursuant to the 10b5-1 Plan. F8 · price: This transaction was executed in multiple trades at prices ranging from $207.30 to $208.19. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Shares are held by the Barbara Kahn TTEE Barbara Kahn Rev TRT DTD 6/26/96 & Robert Meyer TTEE Robert Meyer Rev Trst DTD 6/26/96, with respect to which the reporting person is a trustee. Read SEC document |
| December 12, 2019 Filed Dec 17, 2019 02:16 UTC |
KAHN BARBARADirector
|
SaleCommon Stock | 600 | $206.53 | $123,915.00 |
DisclosureSEC source: 0001093557-19-000258 · edgardoc.xml · nonDerivative · entry 5 KAHN BARBARA · CIK 0001520391 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 13,366 F1 · shares: On September 13, 2019, Ms. Kahn adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Kahn. The exercise and sale of shares set forth above were pursuant to the 10b5-1 Plan. F7 · price: This transaction was executed in multiple trades at prices ranging from $206.14 to $207.12. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Shares are held by the Barbara Kahn TTEE Barbara Kahn Rev TRT DTD 6/26/96 & Robert Meyer TTEE Robert Meyer Rev Trst DTD 6/26/96, with respect to which the reporting person is a trustee. Read SEC document |
| December 12, 2019 Filed Dec 17, 2019 02:16 UTC |
KAHN BARBARADirector
|
SaleCommon Stock | 1,200 | $205.62 | $246,743.04 |
DisclosureSEC source: 0001093557-19-000258 · edgardoc.xml · nonDerivative · entry 4 KAHN BARBARA · CIK 0001520391 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 13,966 F1 · shares: On September 13, 2019, Ms. Kahn adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Kahn. The exercise and sale of shares set forth above were pursuant to the 10b5-1 Plan. F6 · price: This transaction was executed in multiple trades at prices ranging from $205.02 to $206.00. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Shares are held by the Barbara Kahn TTEE Barbara Kahn Rev TRT DTD 6/26/96 & Robert Meyer TTEE Robert Meyer Rev Trst DTD 6/26/96, with respect to which the reporting person is a trustee. Read SEC document |
| December 12, 2019 Filed Dec 17, 2019 02:16 UTC |
KAHN BARBARADirector
|
SaleCommon Stock | 1,000 | $204.23 | $204,231.00 |
DisclosureSEC source: 0001093557-19-000258 · edgardoc.xml · nonDerivative · entry 3 KAHN BARBARA · CIK 0001520391 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 15,166 F1 · shares: On September 13, 2019, Ms. Kahn adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Kahn. The exercise and sale of shares set forth above were pursuant to the 10b5-1 Plan. F5 · price: This transaction was executed in multiple trades at prices ranging from $203.87 to $204.81. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Shares are held by the Barbara Kahn TTEE Barbara Kahn Rev TRT DTD 6/26/96 & Robert Meyer TTEE Robert Meyer Rev Trst DTD 6/26/96, with respect to which the reporting person is a trustee. Read SEC document |
| December 12, 2019 Filed Dec 17, 2019 02:16 UTC |
KAHN BARBARADirector
|
SaleCommon Stock | 1,801 | $202.99 | $365,590.93 |
DisclosureSEC source: 0001093557-19-000258 · edgardoc.xml · nonDerivative · entry 2 KAHN BARBARA · CIK 0001520391 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 16,166 F1 · shares: On September 13, 2019, Ms. Kahn adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Kahn. The exercise and sale of shares set forth above were pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $202.71 to $203.69. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Shares are held by the Barbara Kahn TTEE Barbara Kahn Rev TRT DTD 6/26/96 & Robert Meyer TTEE Robert Meyer Rev Trst DTD 6/26/96, with respect to which the reporting person is a trustee. Read SEC document |
| December 12, 2019 Filed Dec 17, 2019 02:16 UTC |
KAHN BARBARADirector
|
SaleCommon Stock | 2,299 | $202.22 | $464,909.99 |
DisclosureSEC source: 0001093557-19-000258 · edgardoc.xml · nonDerivative · entry 1 KAHN BARBARA · CIK 0001520391 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 17,967 F1 · shares: On September 13, 2019, Ms. Kahn adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Kahn. The exercise and sale of shares set forth above were pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $201.68 to $202.63. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Shares are held by the Barbara Kahn TTEE Barbara Kahn Rev TRT DTD 6/26/96 & Robert Meyer TTEE Robert Meyer Rev Trst DTD 6/26/96, with respect to which the reporting person is a trustee. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 01:42 UTC |
Murphy Patrick MichaelSVP, Legal Affairs
|
SaleCommon Stock | 400 | $226.51 | $90,604.00 |
DisclosureSEC source: 0001093557-19-000255 · edgardoc.xml · nonDerivative · entry 4 Murphy Patrick Michael · CIK 0001692785 · SVP, Legal Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,447 F1 · shares: On September 10, 2019, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F6 · price: This transaction was executed in multiple trades at prices ranging from $226.07 to $226.88. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 22,016 unvested restricted stock units, 11,714 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 8,408 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 1,894 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 01:42 UTC |
Murphy Patrick MichaelSVP, Legal Affairs
|
SaleCommon Stock | 1,219 | $225.55 | $274,950.20 |
DisclosureSEC source: 0001093557-19-000255 · edgardoc.xml · nonDerivative · entry 3 Murphy Patrick Michael · CIK 0001692785 · SVP, Legal Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,847 F1 · shares: On September 10, 2019, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F5 · price: This transaction was executed in multiple trades at prices ranging from $225.05 to $226.00. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 22,016 unvested restricted stock units, 11,714 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 8,408 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 1,894 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 01:42 UTC |
Murphy Patrick MichaelSVP, Legal Affairs
|
SaleCommon Stock | 1,999 | $224.36 | $448,495.64 |
DisclosureSEC source: 0001093557-19-000255 · edgardoc.xml · nonDerivative · entry 2 Murphy Patrick Michael · CIK 0001692785 · SVP, Legal Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,066 F1 · shares: On September 10, 2019, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $224.01 to $225.00. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 22,016 unvested restricted stock units, 11,714 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 8,408 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 1,894 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 01:42 UTC |
Murphy Patrick MichaelSVP, Legal Affairs
|
SaleCommon Stock | 1,900 | $223.31 | $424,296.41 |
DisclosureSEC source: 0001093557-19-000255 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · SVP, Legal Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,065 F1 · shares: On September 10, 2019, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $223.01 to $224.00. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 22,016 unvested restricted stock units, 11,714 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 8,408 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 1,894 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| December 03, 2019 Filed Dec 5, 2019 21:22 UTC |
FOLETTA MARK GDirector
|
SaleCommon Stock | 462 | $228.93 | $105,766.49 |
DisclosureSEC source: 0001093557-19-000253 · edgardoc.xml · nonDerivative · entry 5 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 16,147 F1 · shares: On August 30, 2019, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan. F5 · price: This transaction was executed in multiple trades at prices ranging from $228.46 to $229.50. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee. Read SEC document |
| December 03, 2019 Filed Dec 5, 2019 21:22 UTC |
FOLETTA MARK GDirector
|
SaleCommon Stock | 233 | $227.66 | $53,045.64 |
DisclosureSEC source: 0001093557-19-000253 · edgardoc.xml · nonDerivative · entry 4 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 16,609 F1 · shares: On August 30, 2019, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $227.16 to $228.09. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee. Read SEC document |
| December 03, 2019 Filed Dec 5, 2019 21:22 UTC |
FOLETTA MARK GDirector
|
SaleCommon Stock | 232 | $226.20 | $52,478.45 |
DisclosureSEC source: 0001093557-19-000253 · edgardoc.xml · nonDerivative · entry 3 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 16,842 F1 · shares: On August 30, 2019, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan. F3 · price: This transaction was executed in multiple trades at prices ranging from $225.615 to $226.60. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee. Read SEC document |
| December 03, 2019 Filed Dec 5, 2019 21:22 UTC |
FOLETTA MARK GDirector
|
SaleCommon Stock | 70 | $223.41 | $15,638.70 |
DisclosureSEC source: 0001093557-19-000253 · edgardoc.xml · nonDerivative · entry 2 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 17,074 F1 · shares: On August 30, 2019, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee. Read SEC document |
| December 03, 2019 Filed Dec 5, 2019 21:22 UTC |
FOLETTA MARK GDirector
|
SaleCommon Stock | 3 | $221.34 | $664.02 |
DisclosureSEC source: 0001093557-19-000253 · edgardoc.xml · nonDerivative · entry 1 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 17,144 F1 · shares: On August 30, 2019, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee. Read SEC document |
| December 02, 2019 Filed Dec 5, 2019 01:04 UTC |
SAYER KEVIN RDirector · President, CEO and Chairman
|
SaleCommon Stock | 2,128 | $222.76 | $474,024.77 |
DisclosureSEC source: 0001093557-19-000251 · edgardoc.xml · nonDerivative · entry 5 SAYER KEVIN R · CIK 0001286858 · Director · President, CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,937 F1 · shares: On May 15, 2019, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan. F7 · price: This transaction was executed in multiple trades at prices ranging from $222.61 to $222.97. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 89,648 unvested restricted stock units, 35,829 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 40,272 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 13,547 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| December 02, 2019 Filed Dec 5, 2019 01:04 UTC |
SAYER KEVIN RDirector · President, CEO and Chairman
|
SaleCommon Stock | 3,992 | $222.12 | $886,689.47 |
DisclosureSEC source: 0001093557-19-000251 · edgardoc.xml · nonDerivative · entry 4 SAYER KEVIN R · CIK 0001286858 · Director · President, CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,065 F1 · shares: On May 15, 2019, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan. F6 · price: This transaction was executed in multiple trades at prices ranging from $221.59 to $222.50. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 89,648 unvested restricted stock units, 35,829 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 40,272 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 13,547 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| December 02, 2019 Filed Dec 5, 2019 01:04 UTC |
SAYER KEVIN RDirector · President, CEO and Chairman
|
SaleCommon Stock | 900 | $220.95 | $198,853.02 |
DisclosureSEC source: 0001093557-19-000251 · edgardoc.xml · nonDerivative · entry 3 SAYER KEVIN R · CIK 0001286858 · Director · President, CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,057 F1 · shares: On May 15, 2019, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan. F5 · price: This transaction was executed in multiple trades at prices ranging from $220.55 to $221.545. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 89,648 unvested restricted stock units, 35,829 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 40,272 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 13,547 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| December 02, 2019 Filed Dec 5, 2019 01:04 UTC |
SAYER KEVIN RDirector · President, CEO and Chairman
|
SaleCommon Stock | 2,600 | $219.68 | $571,169.04 |
DisclosureSEC source: 0001093557-19-000251 · edgardoc.xml · nonDerivative · entry 2 SAYER KEVIN R · CIK 0001286858 · Director · President, CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,957 F1 · shares: On May 15, 2019, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $219.20 to $220.15. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 89,648 unvested restricted stock units, 35,829 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 40,272 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 13,547 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| December 02, 2019 Filed Dec 5, 2019 01:04 UTC |
SAYER KEVIN RDirector · President, CEO and Chairman
|
SaleCommon Stock | 380 | $218.28 | $82,948.00 |
DisclosureSEC source: 0001093557-19-000251 · edgardoc.xml · nonDerivative · entry 1 SAYER KEVIN R · CIK 0001286858 · Director · President, CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,557 F1 · shares: On May 15, 2019, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $218.15 to $218.66. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 89,648 unvested restricted stock units, 35,829 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 40,272 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 13,547 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| November 22, 2019 Filed Nov 26, 2019 00:43 UTC |
DOUBLEDAY RICHARDEVP Chief Commercial Officer
|
SaleCommon Stock | 233 | $218.52 | $50,915.39 |
DisclosureSEC source: 0001093557-19-000249 · edgardoc.xml · nonDerivative · entry 2 DOUBLEDAY RICHARD · CIK 0001466545 · EVP Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 15,311 F1 · shares: On June 3, 2019, Mr. Doubleday adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Doubleday. The shares set forth above were sold pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $218.11 to $218.33. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Doubleday Living Trust U/A/D 5/26/2015, with respect to which the reporting person is a trustee. Read SEC document |
| November 22, 2019 Filed Nov 26, 2019 00:43 UTC |
DOUBLEDAY RICHARDEVP Chief Commercial Officer
|
SaleCommon Stock | 1,300 | $217.39 | $282,604.01 |
DisclosureSEC source: 0001093557-19-000249 · edgardoc.xml · nonDerivative · entry 1 DOUBLEDAY RICHARD · CIK 0001466545 · EVP Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 15,544 F1 · shares: On June 3, 2019, Mr. Doubleday adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Doubleday. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $217.06 to $217.47. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Doubleday Living Trust U/A/D 5/26/2015, with respect to which the reporting person is a trustee. Read SEC document |
| November 22, 2019 Filed Nov 26, 2019 00:42 UTC |
Pacelli Steven RobertEVP Strategy and Corporate Dev
|
SaleCommon Stock | 232 | $218.52 | $50,696.06 |
DisclosureSEC source: 0001093557-19-000248 · edgardoc.xml · nonDerivative · entry 2 Pacelli Steven Robert · CIK 0001359098 · EVP Strategy and Corporate Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,219 F1 · shares: On June 11, 2019, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $218.11 to $218.83. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 38,823 unvested restricted stock units, 14,987 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 19,251 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 4,585 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| November 22, 2019 Filed Nov 26, 2019 00:42 UTC |
Pacelli Steven RobertEVP Strategy and Corporate Dev
|
SaleCommon Stock | 1,300 | $217.39 | $282,604.01 |
DisclosureSEC source: 0001093557-19-000248 · edgardoc.xml · nonDerivative · entry 1 Pacelli Steven Robert · CIK 0001359098 · EVP Strategy and Corporate Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,451 F1 · shares: On June 11, 2019, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $217.06 to $217.47. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 38,823 unvested restricted stock units, 14,987 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 19,251 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 4,585 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| November 21, 2019 Filed Nov 25, 2019 23:20 UTC |
Abbey DonaldEVP Quality and Regulatory Aff
|
SaleCommon Stock | 2,990 | $221.16 | $661,257.34 |
DisclosureSEC source: 0001093557-19-000245 · edgardoc.xml · nonDerivative · entry 4 Abbey Donald · CIK 0001534342 · EVP Quality and Regulatory Aff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,946 F1 · shares: On August 23, 2019, Mr. Abbey adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Abbey. The shares set forth above were sold pursuant to the 10b5-1 Plan. F6 · price: This transaction was executed in multiple trades at prices ranging from $221.00 to $221.86. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 38,823 restricted stock units, 14,987 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 19,251 of which were granted on March 8, 2018 and shall vest through March 8, 2021 and 4,585 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| November 21, 2019 Filed Nov 25, 2019 23:20 UTC |
Abbey DonaldEVP Quality and Regulatory Aff
|
SaleCommon Stock | 4,259 | $220.50 | $939,106.94 |
DisclosureSEC source: 0001093557-19-000245 · edgardoc.xml · nonDerivative · entry 3 Abbey Donald · CIK 0001534342 · EVP Quality and Regulatory Aff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,936 F1 · shares: On August 23, 2019, Mr. Abbey adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Abbey. The shares set forth above were sold pursuant to the 10b5-1 Plan. F5 · price: This transaction was executed in multiple trades at prices ranging from $220.00 to $220.99. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 38,823 restricted stock units, 14,987 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 19,251 of which were granted on March 8, 2018 and shall vest through March 8, 2021 and 4,585 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| November 21, 2019 Filed Nov 25, 2019 23:20 UTC |
Abbey DonaldEVP Quality and Regulatory Aff
|
SaleCommon Stock | 3,037 | $219.65 | $667,067.94 |
DisclosureSEC source: 0001093557-19-000245 · edgardoc.xml · nonDerivative · entry 2 Abbey Donald · CIK 0001534342 · EVP Quality and Regulatory Aff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,195 F1 · shares: On August 23, 2019, Mr. Abbey adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Abbey. The shares set forth above were sold pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $219.00 to $219.99. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 38,823 restricted stock units, 14,987 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 19,251 of which were granted on March 8, 2018 and shall vest through March 8, 2021 and 4,585 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| November 21, 2019 Filed Nov 25, 2019 23:20 UTC |
Abbey DonaldEVP Quality and Regulatory Aff
|
SaleCommon Stock | 1,318 | $218.43 | $287,896.80 |
DisclosureSEC source: 0001093557-19-000245 · edgardoc.xml · nonDerivative · entry 1 Abbey Donald · CIK 0001534342 · EVP Quality and Regulatory Aff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,232 F1 · shares: On August 23, 2019, Mr. Abbey adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Abbey. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $217.98 to $218.81. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 38,823 restricted stock units, 14,987 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 19,251 of which were granted on March 8, 2018 and shall vest through March 8, 2021 and 4,585 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| November 07, 2019 Filed Nov 9, 2019 01:58 UTC |
AUGUSTINOS NICHOLASDirector
|
SaleCommon Stock | 1,208 | $185.29 | $223,830.32 |
DisclosureSEC source: 0001093557-19-000241 · edgardoc.xml · nonDerivative · entry 1 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,854 F1 · shares: On March 1, 2019, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 2,676 restricted stock units which were granted on May 31, 2019 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2020 Annual Meeting. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 23:20 UTC |
SAYER KEVIN RDirector · President, CEO and Chairman
|
SaleCommon Stock | 2,500 | $158.57 | $396,422.50 |
DisclosureSEC source: 0001093557-19-000239 · edgardoc.xml · nonDerivative · entry 3 SAYER KEVIN R · CIK 0001286858 · Director · President, CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,937 F1 · shares: On May 15, 2019, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan. F5 · price: This transaction was executed in multiple trades at prices ranging from $158.10 to $158.99. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 89,648 unvested restricted stock units, 35,829 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 40,272 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 13,547 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 23:20 UTC |
SAYER KEVIN RDirector · President, CEO and Chairman
|
SaleCommon Stock | 4,470 | $157.42 | $703,646.84 |
DisclosureSEC source: 0001093557-19-000239 · edgardoc.xml · nonDerivative · entry 2 SAYER KEVIN R · CIK 0001286858 · Director · President, CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,437 F1 · shares: On May 15, 2019, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $157.10 to $158.04. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 89,648 unvested restricted stock units, 35,829 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 40,272 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 13,547 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 23:20 UTC |
SAYER KEVIN RDirector · President, CEO and Chairman
|
SaleCommon Stock | 3,030 | $156.75 | $474,947.35 |
DisclosureSEC source: 0001093557-19-000239 · edgardoc.xml · nonDerivative · entry 1 SAYER KEVIN R · CIK 0001286858 · Director · President, CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,907 F1 · shares: On May 15, 2019, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $156.10 to $157.07. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 89,648 unvested restricted stock units, 35,829 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 40,272 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 13,547 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| October 23, 2019 Filed Oct 25, 2019 20:35 UTC |
Pacelli Steven RobertEVP Strategy and Corporate Dev
|
SaleCommon Stock | 210 | $153.34 | $32,202.24 |
DisclosureSEC source: 0001093557-19-000226 · edgardoc.xml · nonDerivative · entry 3 Pacelli Steven Robert · CIK 0001359098 · EVP Strategy and Corporate Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,751 F1 · shares: On June 11, 2019, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan. F5 · price: This transaction was executed in multiple trades at prices ranging from $153.34 to $153.43. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 38,823 unvested restricted stock units, 14,987 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 19,251 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 4,585 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| October 23, 2019 Filed Oct 25, 2019 20:35 UTC |
Pacelli Steven RobertEVP Strategy and Corporate Dev
|
SaleCommon Stock | 681 | $152.71 | $103,996.53 |
DisclosureSEC source: 0001093557-19-000226 · edgardoc.xml · nonDerivative · entry 2 Pacelli Steven Robert · CIK 0001359098 · EVP Strategy and Corporate Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,961 F1 · shares: On June 11, 2019, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $152.21 to $153.13. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 38,823 unvested restricted stock units, 14,987 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 19,251 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 4,585 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.